GlassScriptPhysician profile
Renee E Roesch
NPI 1871361618
$2,378.91
in general payments reported to CMS, 2019-2025
12 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,858 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,793 · Travel and Lodging: $531 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,792.85 |
| Travel and Lodging | $531.07 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $531.07 | 2024 | Inspire |
| Harmony Biosciences LLC | $408.84 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $386.17 | 2024-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $237.41 | 2024-2025 | Tezspire, Airsupra |
| Genzyme Corporation | $211.06 | 2024-2025 | |
| Teleflex LLC | $154.00 | 2024 | Urolift |
| Glaxosmithkline, LLC. | $133.83 | 2024-2025 | Nucala |
| Avadel Cns Pharmaceuticals, LLC | $115.86 | 2024-2025 | Lumryz |
| Grifols USA, LLC | $69.46 | 2024-2025 | Prolastin-C Liquid |
| Itamar Medical INC | $65.08 | 2024-2025 | Watchpatone |
| Seqirus USA INC | $36.15 | 2025 | Flucelvax, Fluad |
| Fisher & Paykel Healthcare INC | $29.98 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Roesch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.